Literature DB >> 23782099

Molecular dynamics investigation on the poor sensitivity of A171T mutant NEDD8-activating enzyme (NAE) for MLN4924.

Sharad Verma1, Amit Singh, Abha Mishra.   

Abstract

MLN4924 is an adenosine sulfamate analog that generates the inhibitory NEDD8-MLN4924 covalent complex. A single nucleotide transition that changes alanine 171 to threonine (A171T) of the NAE subunit UBA3 reduces the enzyme's sensitivity for MLN4924. Our molecular dynamics simulation study revealed that A171T transition brought remarkable conformational changes in enzyme structure (open ATP binding pocket), which reduced the interaction between MLN4924 and ATP binding pocket while wild form completely covered the MLN4924. A total difference of -49.75 kJ/mol was noticed in interaction energy (electrostatic and van der Waals) during simulation between mutant and wild form with MLN4924. Superimposition of final 20 ns mutant structure with reference structure showed significant change in native binding position as compared to wild form. Results were found in coherence with the recently reported in vitro studies which states that A171T transition leads to change in ATP binding pocket structure.

Entities:  

Keywords:  A171T mutant NAE; MLN4924; NEDD8-activating enzyme; essential dynamics; molecular dynamics simulation

Mesh:

Substances:

Year:  2013        PMID: 23782099     DOI: 10.1080/07391102.2013.804436

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  2 in total

1.  Molecular dynamics simulation on the low sensitivity of mutants of NEDD-8 activating enzyme for MLN4924 inhibitor as a cancer drug.

Authors:  Behnam Rashidieh; Mohharam Valizadeh; Vahideh Assadollahi; Mohammad Mehdi Ranjbar
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

2.  Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma.

Authors:  Jingrong Xian; Shiwen Wang; Yanyu Jiang; Lihui Li; Lili Cai; Ping Chen; Yue Liu; Xiaofei Zeng; Guoan Chen; Chen Ding; Robert M Hoffman; Lijun Jia; Hu Zhao; Yanmei Zhang
Journal:  Cancer Biol Med       Date:  2021-03-18       Impact factor: 5.347

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.